Ming-Kuei Jang
Amministratore Delegato presso Aprinoia Therapeutics, Inc.
Provenienza dei contatti di primo grado di Ming-Kuei Jang
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Aprinoia Therapeutics, Inc. /US/
Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA.
9
| Private Company | Biotechnology | 9 |
Aprinoia Therapeutics, Inc.
Aprinoia Therapeutics, Inc. BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a drug discovery and early development company. The company was founded by Ming-Kuei Jang in May 20, 2015 and is headquartered in Taipei, Taiwan.
3
| Private Company | Biotechnology | 3 |
Glaxosmithkline China Ltd.
1
| Subsidiary | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Ming-Kuei Jang tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Thomas Jefferson University | College/University | Corporate Officer/Principal | |
MOLECULAR PHARMACOLOGY (USA), LTD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Janssen R&D Ireland Ltd. | President | ||
NAVER CORPORATION | Packaged Software | Corporate Officer/Principal | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering, Inc. (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Massachusetts Institute of Technology | College/University | Graduate Degree | |
The Johns Hopkins University | College/University | Undergraduate Degree | |
University of Bristol | College/University | Undergraduate Degree | |
APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Chief Tech/Sci/R&D Officer | |
SK, Inc. (Korea)
SK, Inc. (Korea) Financial ConglomeratesFinance SK Group distributes refined oil and gas. It provides petroleum-refining services, energy products like crude oil, natural gas and refined petroleum. The firm's services are generation, transmission & distribution of electricity, natural gas and water and marketing & trading of energy commodities. The company was founded by Jong-Kun in 1953 and is located in Jongno, South Korea. | Financial Conglomerates | Corporate Officer/Principal | |
The University of Nottingham | College/University | Doctorate Degree | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
National Central University | College/University | Graduate Degree | |
Seoul National University | College/University | Undergraduate Degree | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Director/Board Member | |
Sidney Kimmel Medical College | College/University | Corporate Officer/Principal | |
Institute of Human Virology
Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Other Consumer Services | Chairman | |
CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer | |
Johnson & Johnson Pharmaceutical Group | Corporate Officer/Principal | ||
Tibotec Pharmaceuticals | Chief Executive Officer | ||
COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Chairman | |
Amerigen Pharmaceuticals Ltd.
Amerigen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Amerigen Pharmaceuticals Ltd. engages in the development, manufacturing, and sale of generic pharmaceutical products. The company was founded in 2007 and is headquartered in Lyndhurst, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
RUBIUS THERAPEUTICS | Biotechnology | Director/Board Member | |
MUSTANG BIO, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Silicon INSITE, Inc.
Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chairman | |
CONVATEC GROUP PLC | Medical Specialties | Corporate Officer/Principal | |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chairman | |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Investment Managers | Chief Executive Officer Chairman | |
Janssen Therapeutics, Inc. | President | ||
WOORI VENTURE PARTNERS CO., LTD | Investment Managers | Director/Board Member | |
Pomerantz Life Sciences Consulting Group LLC | President | ||
ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
On Demand Pharmaceuticals, Inc.
On Demand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology On Demand Pharmaceuticals, Inc. is an innovative technology company that is transforming the way medicines are made. On Demand Pharmaceuticals is based in Richmond, VA and was founded by Shiu Fei Ling. The private company's breakthrough manufacturing technology platform, the Pharmacy on Demand (POD), allows for the production of medicines on demand, wherever and whenever they are needed. The company's mission is to provide an adequate, safe, and reliable supply of medicines to every community worldwide. | Pharmaceuticals: Major | Director of Finance/CFO | |
Merck Sharp & Dohme Research Laboratories Neuroscience Researc | Corporate Officer/Principal | ||
VIRACTA THERAPEUTICS, INC. | Biotechnology | Chairman | |
INDAPTUS THERAPEUTICS, INC. | Chairman | ||
Wuxi Cds Clinical Research Shanghai Co. Ltd. | Corporate Officer/Principal | ||
PPD Pharmaceuticals Research & Development Beijing Co. Ltd. | Corporate Officer/Principal | ||
Ubp Greater China Shanghai Co. Ltd. | Corporate Officer/Principal | ||
Cali Shenzhen Biosciences Co. Ltd. | Chief Executive Officer | ||
Cali Biosciences Co. Ltd.
Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China. | Biotechnology | Chief Executive Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 29 |
Cina | 6 |
Corea del Sud | 5 |
Regno Unito | 5 |
Israele | 4 |
Settori
Health Technology | 22 |
Consumer Services | 9 |
Finance | 6 |
Commercial Services | 2 |
Technology Services | 2 |
Posizioni
Director/Board Member | 41 |
Corporate Officer/Principal | 39 |
Chairman | 26 |
Chief Executive Officer | 14 |
Undergraduate Degree | 10 |
Contatti più connessi
Insiders | |
---|---|
Roger Pomerantz | 30 |
Walter Moos | 30 |
Xin Hui | 14 |
Jun Bao | 12 |
Lana Gladstein | 11 |
Mark Shearman | 10 |
Poe-Jou Chen | 9 |
Zhi Gang Luo | 8 |
Brian Achenbach | 8 |
Kuk-Hyun Kyung | 5 |
Chien Hui Hung | 2 |
Masaomi Miyamoto | 1 |
- Borsa valori
- Insiders
- Ming-Kuei Jang
- Connessioni Società